Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, Lancet Oncol, vol.10, issue.5, pp.459-466, 2009. ,
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N Engl J Med, vol.352, issue.10, pp.987-996, 2005. ,
Antiangiogenic therapy for glioblastoma: the challenge of translating response rate into efficacy, Am Soc Clin Oncol Educ Book, 2013. ,
Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma, J Clin Oncol Off J Am Soc Clin Oncol, vol.31, issue.26, pp.3212-3218, 2013. ,
Bevacizumab for the treatment of high-grade glioma: an update after phase III trials, Expert Opin Biol Ther, vol.14, issue.5, pp.729-740, 2014. ,
Glioma: experimental models and reality, Acta Neuropathologica, vol.133, issue.2, pp.263-282, 2017. ,
Tumor angiogenesis: therapeutic implications, N Engl J Med, vol.285, issue.21, pp.1182-1186, 1971. ,
Angiogenesis in glioblastoma, N Engl J Med, vol.369, issue.16, pp.1561-1563, 2013. ,
Mechanisms of glioma-associated neovascularization, Am J Pathol, vol.181, issue.4, pp.1126-1141, 2012. ,
Tumor angiogenesis and antiangiogenic therapy in malignant gliomas revisited. Acta Neuropathologica, vol.124, pp.763-775, 2012. ,
New directions in anti-angiogenic therapy for glioblastoma, Neurotherapeutics, vol.14, issue.2, pp.321-332, 2017. ,
The glioblastoma vasculature as a target for cancer therapy, Biochm Soc Trans, vol.42, issue.6, pp.1647-1652, 2014. ,
Angiogenesis in brain tumours, Nat Rev Neurosci, 2007. ,
Novel endogenous angiogenesis inhibitors and their therapeutic potential, Acta Pharmacol Sin, vol.36, issue.10, pp.1177-1190, 2015. ,
Up-regulation of microRNA-16 in glioblastoma inhibits the function of endothelial cells and tumor angiogenesis by targeting Bmi-1, ACAMC, vol.16, issue.5, pp.609-620, 2016. ,
Angiogenesis in gliomas: imaging and experimental therapeutics, Brain Pathology, vol.15, issue.4, pp.342-363, 2005. ,
Endogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapy, Neuro-Oncol, vol.7, issue.2, pp.106-121, 2005. ,
A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastoma, Arch Neurol, vol.67, issue.3, pp.313-319, 2010. ,
A review of antiangiogenic targets for monoclonal antibody cancer therapy, Int J Mol Sci, vol.18, issue.8, p.1786, 2017. ,
The future of antiangiogenic treatment in glioblastoma, Current Opinion in Neurology, vol.27, issue.6, pp.675-682, 2014. ,
Bevacizumab for newly diagnosed glioblastoma, N Engl J Med, vol.370, issue.21, pp.2048-2049, 2014. ,
Randomized, double-blind, placebo-controlled, multicenter phase ii study of onartuzumab plus bevacizumab versus placebo plus bevacizumab in patients with recurrent glioblastoma: efficacy, safety, and hepatocyte growth factor and O 6 -methylguanine-DNA methyltransferase biomarker analyses, J Clin Oncol Off J Am Soc Clin Oncol, vol.35, issue.3, pp.343-351, 2017. ,
Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?, Angiogenesis, vol.13, issue.1, pp.1-14, 2010. ,
New perspectives in glioblastoma antiangiogenic therapy, Wspó?czesna Onkologia, 2016. ,
Phase II study of aflibercept in recurrent malignant glioma: a North American brain tumor Consortium study, J Clin Oncol Off J Am Soc Clin Oncol, vol.29, pp.2689-2695, 2011. ,
Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma, Cancer, vol.124, issue.7, pp.1438-1448, 2018. ,
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome, Oncotarget, 2016. ,
Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy, Science, vol.307, issue.5706, pp.58-62, 2005. ,
A perivascular niche for brain tumor stem cells, Cancer Cell, vol.11, issue.1, pp.69-82, 2007. ,
Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth, Cell, vol.153, issue.1, pp.139-152, 2013. ,
Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors, Cancer Res, vol.67, issue.8, pp.3560-3564, 2007. ,
Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept, Clinical Cancer Research, vol.17, issue.14, pp.4872-4881, 2011. ,
Adverse effects of anticancer agents that target the VEGF pathway, Nat Rev Clin Oncol, vol.6, issue.8, pp.465-477, 2009. ,
Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies, J Neurosurg, vol.269, issue.3, pp.191-200, 2017. ,
Convection-enhanced delivery, Neurotherapeutics, vol.14, issue.2, pp.358-371, 2017. ,
Convection-enhanced delivery of neurotherapeutics, Advances in Neurotherapeutic Delivery Technologies, vol.8, 2015. ,
Convection-enhanced delivery for the treatment of glioblastoma, Neuro-Oncology, vol.17, issue.2, pp.3-8, 2015. ,
Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals, Neurosurg Focus, vol.62, issue.3, p.8, 2015. ,
Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping Beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma, Molecular Therapy, 2005. ,
RNA interference targeting hypoxia-inducible factor 1? via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model, J Neurosurg, vol.122, issue.2, pp.331-341, 2015. ,
Efficacy of antiangiogenic targeted immunotoxin DTAT and DTATEGF against glioblastoma multiforme ,
, Zhong Nan Da Xue Xue Bao Yi Xue Ban, vol.39, pp.1-5, 2014.
Improvement in the standard treatment for experimental glioma by fusing antibody Fc domain to endostatin, J Neurosurg, vol.284, issue.6, pp.1139-1146, 2011. ,
Antiangiogenic therapy by local intracerebral microinfusion improves treatment efficiency and survival in an orthotopic human glioblastoma model, Clin Cancer Res, vol.10, issue.4, pp.1255-1262, 2004. ,
Antiangiogenic effect of inhibitors of cytochrome P450 on rats with glioblastoma multiforme, J Cereb Blood Flow Metab, vol.28, issue.8, pp.1431-1439, 2008. ,
Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma, Drug Delivery, vol.25, issue.1, pp.1756-1765, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01908758
Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors, Neuro-Oncol, vol.10, issue.3, pp.320-329, 2008. ,
, International Journal of Nanomedicine, 2019.
Biomaterial-based implantable devices for cancer therapy, Adv Healthcare Mater, vol.6, issue.2, p.1600766, 2017. ,
Polymeric drug delivery for the treatment of glioblastoma, Neuro-Oncology, vol.17, issue.2, pp.9-23, 2015. ,
Recent advances in polyanhydride based biomaterials, Adv Mater Deerfield Beach Fla, vol.30, issue.41, p.1706815, 2018. ,
Interstitial chemotherapy with biodegradable BCNU (Gliadel) wafers in the treatment of malignant gliomas, Ther Clin Risk Manag, vol.3, issue.5, pp.707-715, 2007. ,
Biodegradable polymer implants to treat brain tumors, J Control Release, vol.74, issue.1-3, pp.63-67, 2001. ,
Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain, Cancer Res, vol.53, issue.2, pp.329-333, 1993. ,
Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastomas, Acta Neurochirurgica, vol.154, issue.8, pp.1379-1381, 2012. ,
Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review, World J Surg Onc, vol.14, issue.1, p.225, 2016. ,
Local delivery of angiogenesisinhibitor minocycline combined with radiotherapy and oral temozolomide chemotherapy in 9L glioma, J Neurosurg, vol.11, issue.4, pp.662-669, 2014. ,
Local delivery of minocycline and systemic BCNU have synergistic activity in the treatment of intracranial glioma, J Neurooncol, vol.64, issue.3, pp.203-209, 2003. ,
The role of minocycline in the treatment of intracranial 9L glioma, J Neurosurg, vol.48, issue.4, pp.635-640, 1995. ,
Functionalizing PLGA and PLGA derivatives for drug delivery and tissue regeneration applications, Adv Healthcare Mater, vol.7, issue.1, p.1701035, 2018. ,
Recent applications of PLGA based nanostructures in drug delivery, Colloids and Surfaces B: Biointerfaces, vol.159, pp.217-231, 2017. ,
Targeted concurrent and sequential delivery of chemotherapeutic and antiangiogenic agents to the brain by using drug-loaded nanofibrous membranes, Int J Nanomedicine, vol.12, pp.1265-1276, 2017. ,
Enhanced composite electrospun nanofiber scaffolds for use in drug delivery, Expert Opin Drug Deliv, vol.5, issue.10, pp.1093-1106, 2008. ,
Concurrent delivery of carmustine, irinotecan, and cisplatin to the cerebral cavity using biodegradable nanofibers: in vitro and in vivo studies, Colloids and Surfaces B: Biointerfaces, vol.134, pp.254-261, 2015. ,
Development of a gene/drug dual delivery system for brain tumor therapy: potent inhibition via RNA interference and synergistic effects, Biomaterials, vol.34, issue.30, pp.7483-7494, 2013. ,
Advanced interstitial chemotherapy combined with targeted treatment of malignant glioma in rats by using drug-loaded nanofibrous membranes, Oncotarget, 2016. ,
In vivo fate and therapeutic efficacy of PF-4/CTF microspheres in an orthotopic human glioblastoma model, Faseb J, vol.22, issue.2, pp.488-499, 2008. ,
Drug encapsulated polymeric microspheres for intracranial tumor therapy: a review of the literature, Adv Drug Deliv Rev, vol.91, pp.23-37, 2015. ,
Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of malignant glioma: a randomized phase II trial, Neurosurgery, vol.56, issue.2, pp.242-248, 2005. ,
Nanotherapeutic systems for local treatment of brain tumors, Wiley Interdiscip Rev Nanomed Nanobiotechnol, vol.10, issue.1, p.1479, 2018. ,
Depot delivery of dexamethasone and cediranib for the treatment of brain tumor associated edema in an intracranial rat glioma model, J Controlled Release, vol.217, pp.183-190, 2015. ,
Multi-pulse drug delivery from a resorbable polymeric microchip device, Nat Mater, vol.2, issue.11, pp.767-772, 2003. ,
Nanocarriers for the treatment of glioblastoma multiforme: current state-of-the-art, J Control Release, vol.227, pp.23-37, 2016. ,
Nanocarriers for cancer-targeted drug delivery, J Drug Target, vol.24, issue.3, pp.179-191, 2016. ,
Applications of nanotechnology in cancer: a literature review of imaging and treatment, J Nucl Med Radiat Ther, vol.05, issue.04, p.195, 2014. ,
Controlled-release nanotherapeutics: state of translation, J Controlled Release, vol.284, pp.39-48, 2018. ,
Enhanced expression of Vastatin inhibits angiogenesis and prolongs survival in murine orthotopic glioblastoma model, BMC Cancer, vol.17, issue.1, p.126, 2017. ,
A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental glioma. Anti-Cancer Drugs, vol.19, pp.133-142, 2008. ,
Natural polymers for the microencapsulation of cells, J R Soc Interface, vol.11, issue.100, p.20140817, 2014. ,
Cell microencapsulation technology: current vision of its therapeutic potential through the administration routes, J Drug Delivery Sci Technol, vol.42, pp.49-62, 2017. ,
Cell microencapsulation with synthetic polymers, J Biomed Mater Res, vol.103, issue.2, pp.846-859, 2015. ,
Applications of cell microencapsulation, Methods Mol Biol Clifton NJ, vol.1479, pp.23-39, 2017. ,
Encapsulated stem cells for cancer therapy, Biomatter, vol.3, issue.1, p.24278, 2013. ,
Local endostatin treatment of gliomas administered by microencapsulated producer cells, Nat Biotechnol, vol.19, issue.1, pp.29-34, 2001. ,
Cell therapy using encapsulated cells producing endostatin, Acta Neurochir Suppl, vol.88, pp.137-141, 2003. ,
Intravital microscopy reveals novel antivascular and antitumor effects of endostatin delivered locally by alginate-encapsulated cells, Cancer Res, vol.61, issue.18, pp.6830-6837, 2001. ,
The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy, Biomaterials, vol.32, issue.8, pp.2106-2116, 2011. ,
Antiangiogenic variant of TSP-1 targets tumor cells in glioblastomas, Mol Ther, vol.23, issue.2, pp.235-243, 2015. ,
Antiangiogenic therapy against experimental glioblastoma using genetically engineered cells producing interferon-alpha, angiostatin, or endostatin, Hum Gene Ther, vol.14, issue.9, pp.883-895, 2003. ,
The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma, Cancer Res, vol.62, issue.20, pp.5657-5663, 2002. ,
PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model, Clin Cancer Res, vol.11, issue.16, pp.5965-5970, 2005. ,
Primary neural stem/ progenitor cells expressing endostatin or cytochrome P450 for gene therapy of glioblastoma, Cancer Gene Ther, vol.15, issue.9, pp.605-615, 2008. ,
Gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cells, Hum Gene Ther, vol.22, issue.6, pp.733-743, 2011. ,
, International Journal of Nanomedicine, 2019.
Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors, Oncogene, vol.29, issue.22, pp.3185-3195, 2010. ,
Gene therapy of rat malignant gliomas using neural stem cells expressing IL-12, DNA and Cell Biol, vol.23, issue.6, pp.381-389, 2004. ,
hMSC-mediated concurrent delivery of endostatin and carboxylesterase to mouse xenografts suppresses glioma initiation and recurrence, Mol Ther, vol.19, issue.6, pp.1161-1169, 2011. ,
Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules, IJN, vol.10, pp.1259-1271, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01392451
Human mesenchymal stromal cells as cellular drug-delivery vectors for glioblastoma therapy: a good deal?, J Exp Clin Cancer Res, vol.36, issue.1, p.135, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-01631360
Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect, Stem Cells Dev, vol.18, issue.5, pp.683-692, 2009. ,
Pulmonary thrombosis in the mouse following intravenous administration of quantum dot-labeled mesenchymal cells, Nanotoxicology, vol.4, issue.1, pp.98-105, 2010. ,
Towards safe, non-viral therapeutic gene expression in humans, Nat Rev Genet, vol.6, issue.4, pp.299-310, 2005. ,
Mesenchymal stem cells: key players in cancer progression, Mol Cancer, vol.16, issue.1, p.31, 2017. ,
Mesenchymal stromal/stem cells in drug therapy: new perspective, Cytotherapy, vol.19, issue.1, pp.19-27, 2017. ,
Tumour-associated mesenchymal stem/ stromal cells: emerging therapeutic targets, Nat Rev Drug Discov, vol.16, issue.1, pp.35-52, 2017. ,
Human-derived normal mesenchymal stem/stromal cells in anticancer therapies, J Cancer, vol.8, issue.1, pp.85-96, 2017. ,
Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis, Pharmacol Ther, vol.143, issue.2, pp.181-196, 2014. ,
Mesenchymal stem cell-derived extracellular vesicles promote angiogenesis: Potencial clinical application, Front Physiol, vol.7, issue.99, p.24, 2016. ,
In vitro and in vivo interactions between glioma and marrow-isolated adult multilineage inducible (Miami) cells, Brain Res, vol.1473, pp.193-203, 2012. ,
Identification of two glioblastoma-associated stromal cell subtypes with different carcinogenic properties in histologically normal surgical margins, J Neurooncol, vol.122, issue.1, pp.1-10, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01117114
Glioblastoma-associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic properties, J Pathol, vol.233, issue.1, pp.74-88, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01064615
Isolation of a new cell population in the glioblastoma microenvironment, J Neurooncol, vol.106, issue.3, pp.493-504, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00626532
Brain mesenchymal stem cells: The other stem cells of the brain?, World J Stem Cells, vol.6, issue.2, pp.134-143, 2014. ,
Mesenchymal stem cells isolated from human gliomas increase proliferation and maintain stemness of glioma stem cells through the IL-6/gp130/STAT3 pathway, Stem Cells, vol.33, issue.8, pp.2400-2415, 2015. ,
Increased in vivo angiogenic effect of glioma stromal mesenchymal stem-like cells on glioma cancer stem cells from patients with glioblastoma, Int J Oncol, vol.42, issue.5, pp.1754-1762, 2013. ,
Tumor-associated mesenchymal stem-like cells provide extracellular signaling cue for invasiveness of glioblastoma cells, Oncotarget, vol.8, issue.1, pp.1438-1448, 2017. ,
Identification of two distinct mesenchymal stromal cell populations in human malignant glioma, J Neurooncol, vol.131, issue.2, pp.245-254, 2017. ,
Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival, Neuro Oncol, vol.19, issue.5, pp.660-668, 2017. ,
Tumor mesenchymal stemlike cell as a prognostic marker in primary glioblastoma, Stem Cells International, vol.2016, issue.1, pp.1-7, 2016. ,
Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas, Oncology, vol.77, issue.1, pp.1-11, 2009. ,
Marrow-Derived B. Bone marrow-derived, endothelial progenitor-like cells as angiogenesisselective gene-targeting vectors, Gene Ther, vol.10, issue.8, pp.647-656, 2003. ,
Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization, Genes Dev, vol.21, issue.12, pp.1546-1558, 2007. ,
Contribution of bone marrowderived endothelial cells to human tumor vasculature, Nat Med, vol.11, issue.3, pp.261-262, 2005. ,
Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas, J Clin Neurosci, vol.16, issue.9, pp.1119-1130, 2009. ,
Nanotheranostics: emerging strategies for early diagnosis and therapy of brain cancer, Nanotheranostics, vol.2, issue.1, pp.70-86, 2018. ,
, International Journal of Nanomedicine, 2019.